Clinical Trials Browser

NIH × alethine × Clear all

NCT00006466 2013-12-18

Beta Alethine in Treating Patients With Myeloma

Phase 1/2 Unknown

Other neoplasmPlasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

NCT00007839 2013-12-18

Beta Alethine in Treating Patients With Low-Grade Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00041379 2013-12-18

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 1/2 Unknown

Lymphoma, Waldenstrom Macroglobulinemia